← Back to Search

Signal Processing Technique

Ideal Binary Mask for Speech Clarity in Dysarthria

Phase < 1
Waitlist Available
Research Sponsored by Utah State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one hour
Awards & highlights

Study Summary

This trial will use an established signal processing technique to see if it can help people with dysarthria, a communication disorder that makes speech hard to understand, to communicate better in noise.

Who is the study for?
This trial is for American English native speakers aged 18-70, with no speech/language impairments or significant exposure to neurogenic speech disorders. Participants must have normal hearing or sensorineural hearing loss within specific thresholds and cannot have conductive/mixed hearing loss, asymmetric hearing loss, cognitive impairments, or very low word recognition ability.Check my eligibility
What is being tested?
The study tests the use of an 'ideal binary mask' signal processing technique on people trying to understand disordered speech in noisy environments. It aims to show how this technology might help those with dysarthria (a motor speech disorder) and listeners with hearing loss.See study design
What are the potential side effects?
Since this trial involves a non-invasive audio processing technique rather than a drug or medical procedure, traditional side effects are not applicable. However, participants may experience fatigue or discomfort from listening tasks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and one hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent correct speech intelligibility

Trial Design

2Treatment groups
Experimental Treatment
Group I: Normal HearingExperimental Treatment1 Intervention
Listeners with normal hearing
Group II: Hearing ImpairedExperimental Treatment1 Intervention
Listeners with hearing loss

Find a Location

Who is running the clinical trial?

Utah State UniversityLead Sponsor
44 Previous Clinical Trials
4,312 Total Patients Enrolled
1 Trials studying Dysarthria
373 Patients Enrolled for Dysarthria

Media Library

Ideal binary mask (Signal Processing Technique) Clinical Trial Eligibility Overview. Trial Name: NCT05244603 — Phase < 1
Dysarthria Research Study Groups: Normal Hearing, Hearing Impaired
Dysarthria Clinical Trial 2023: Ideal binary mask Highlights & Side Effects. Trial Name: NCT05244603 — Phase < 1
Ideal binary mask (Signal Processing Technique) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05244603 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people will be involved in this research project at most?

"Yes, the trial is still ongoing and recruiting patients. The clinical trial was posted on December 1st, 2021 with the most recent update being February 14th, 2022. They are looking for a total of 100 participants from 1 site."

Answered by AI

Are there specific requirements for volunteers of this experiment?

"This medical research is looking for one hundred adult patients with dysarthria. The participants must meet the following requirements: be between 18 and 70 years old, have normal hearing or sensorineural hearing loss, and be native speakers of American English who have had no prior exposure to individuals with neurogenic speech disorders."

Answered by AI

Are there any slots still open for this research opportunity?

"The study, which was first advertised on December 1st 2021, is still recruiting patients according to the latest update from February 14th 2022."

Answered by AI

Does this research include test subjects that are adults?

"This trial is only open to patients aged 18-70. Out of the total number of clinical trials, this age group makes up for 52% of all underaged participants and 136% of senior citizens enrolled in studies."

Answered by AI
~30 spots leftby Apr 2025